CLS's IPO

CLS raised a round of funding on March 21, 2017. Investors include Public.

CLS develops therapies, systems and single-use instruments for gentle and safe thermal treatment of solid cancer tumors. The products are optimized for treatment with immunostimulating interstitial la…

Articles about CLS's IPO: